AASLD welcomes momentum in elevating lifelong liver health as a global public health priority
The American Association for the...
ALEXANDRIA, Virginia — February 3, 2026 – The American Association for the Study of Liver Diseases (AASLD) invites applications...
Dear AASLD Community,
It’s truly an honor to begin this year serving as President of the American Association for the Study of...
Alexandria, VA — The American Association for the Study of Liver Diseases (AASLD) is pleased to announce the leadership of its...
The American Association for the Study of Liver Diseases (AASLD) expresses deep concern over the 2025–2030 Dietary Guidelines...
On January 7, 2026, the Department of Health and Human Services (HHS) and the Department of Agriculture (USDA) released updated...
AASLD develops evidence-based practice guidelines which are updated regularly by a multi-disciplinary panel of experts, including hepatologists, and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care. AASLD also provides practice tools to assist with learning and implementing the new recommendations.
Dr. Elizabeth Verna is the Frank Cardile Associate Professor of Medicine at Columbia University Irving Medical Center, where she practices as transplant hepatologist. Dr. Verna has an active clinical research program in end-stage liver disease and liver transplantation and is the Director of Clinical Research for the Columbia University Transplant Clinical Research Center as well as the Director of Hepatology Research for the Division of Digestive and Liver Diseases.
In 2025, AASLD advanced science, strengthened education, shaped public policy, expanded global engagement, and brought the...
